True about pilocarpine is –
The core concept here is probably its mechanism of action. Pilocarpine is a parasympathomimetic agent. It acts on muscarinic receptors, specifically M3 receptors in the eye, causing contraction of the ciliary muscle and opening of the trabecular meshwork, which lowers intraocular pressure. That's why it's used in glaucoma. Also, it's a direct-acting cholinergic agonist, not a blocker.
Now, the correct answer would be something like it's a muscarinic agonist used in glaucoma. The incorrect options might include things like being a nicotinic agonist, or used for mydriasis instead of miosis, or maybe having sympathomimetic effects. Let me outline possible options.
Option A: "Used in mydriasis." No, pilocarpine causes miosis, so that's wrong. Option B: "Blocks nicotinic receptors." No, it's an agonist. Option C: "Used in glaucoma management." That's correct. Option D: "Beta-2 agonist." No, it's muscarinic.
So the correct answer would be option C. Now, I need to structure the explanation with the required sections. Let me check the character count to stay within 2500. The core concept needs to be concise. Then explain why C is right, why others are wrong, and a clinical pearl. Maybe mention that it's contraindicated in narrow-angle glaucoma? Wait, no, pilocarpine is used in open-angle glaucoma. Wait, actually, pilocarpine can be used in acute angle-closure glaucoma to constrict the pupil and open the angle. That's a key point. So the clinical pearl could be that it's used in angle-closure glaucoma emergencies. Also, remember that it can cause brow ache and miosis. So the pearl might be that it's used in angle-closure glaucoma, and the correct answer is about its use in glaucoma. Need to make sure the explanation is accurate and covers all the points. Let me put it all together now.
**Core Concept**
Pilocarpine is a direct-acting muscarinic receptor agonist used to treat glaucoma by reducing intraocular pressure. Its mechanism involves stimulating M3 muscarinic receptors in the ciliary body and trabecular meshwork, promoting aqueous humor outflow.
**Why the Correct Answer is Right**
Pilocarpine activates M3 muscarinic receptors in the eye, causing contraction of the ciliary muscle and opening of the trabecular meshwork. This enhances uveoscleral and conventional outflow of aqueous humor, lowering intraocular pressure. It is specifically used in open-angle and acute angle-closure glaucoma. Its effect is rapid but short-lived, necessitating frequent dosing.
**Why Each Wrong Option is Incorrect**
**Option A:** "Used in